CaloSense

Lewes, United States · Founded 2022

Headquarters
Lewes, Delaware
Founded
2022
Last Round
Seed
Rounds
1

About

CaloSense is a comprehensive pre- and post-bariatric surgery program with two major value propositions: Dramatically increase the conversion rate of potential patients to actual surgeries, resulting in more surgeries for clinics. Improve long-term patient outcomes, addressing the 35% of patients who regain weight, and reducing costs for health insurance.

Summary

CaloSense is a Digital Health company based in Lewes, United States, founded in 2022. Investors include Techstars and BNP Paribas.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed Round

Investors

Similar Companies